The research-driven company is looking for acquisitions in Europe and North America.
"We are global leaders in enzymes manufacturing and looking at an inorganic growth through acquisitions in R&D space in Europe, North America or Mexico.
"We have strong presence in the US and India and now plan to increase footprints in Europe and Asian markets," Advanced Enzyme Managing Director C L Rathi told PTI here.
"Being a research-driven company, we have invested significant resources in the R&D of various enzymes, proprietary enzyme products and customised enzyme solutions since inception. Going forward, we are looking at expanding in overseas markets through acquisition of a R&D company," he said.
More From This Section
The recent buyout of Hyderabad-based JC Biotech will help the company in boosting market share in the enzymes space and enable it to enter the biopharmaceutical molecules segment. The acquisition will also contribute around Rs 120 crore in the topline this year, Rathi said.
The company is also setting up a marketing subsidiary and marketing office in Malaysia, the managing director said.
Rathi said the company's US operation contributes 50 per cent of its revenues.
The company offers its products and solutions to a global clientele of more than 700 customers spanning across 50 countries. It manufactures enzymes using all four existing natural origins - plant, fungal, bacterial and animal sources.
Enzymes are used in a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, speciality applications, textile processing and others.